Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Front Immunol. 2019 Dec 13;10:2895. doi: 10.3389/fimmu.2019.02895. eCollection 2019.
The multifaceted roles of Innate Lymphoid Cells (ILC) have been widely interrogated in tumor immunity. Whereas, Natural Killer (NK) cells possess undisputable tumor-suppressive properties across multiple types of cancer, the other ILC family members can either promote or inhibit tumor growth depending on the environmental conditions. The differential effects of ILCs on tumor outcome have been attributed to the high degree of heterogeneity and plasticity within the ILC family members. However, it is now becoming clear that ILCs responses are shaped by their dynamic crosstalk with the different components of the tumor microenvironment (TME). In this review, we will give insights into the molecular and cellular players of the ILCs-TME interactions and we will discuss how we can use this knowledge to successfully harness the activity of ILCs for anticancer therapies.
先天淋巴细胞 (ILC) 的多效性作用已在肿瘤免疫中得到广泛研究。而自然杀伤 (NK) 细胞在多种类型的癌症中具有无可争议的肿瘤抑制特性,其他 ILC 家族成员则根据环境条件促进或抑制肿瘤生长。ILC 对肿瘤结局的不同影响归因于 ILC 家族成员的高度异质性和可塑性。然而,现在越来越清楚的是,ILC 的反应受到它们与肿瘤微环境 (TME) 不同成分的动态串扰的影响。在这篇综述中,我们将深入探讨 ILC-TME 相互作用的分子和细胞参与者,并讨论我们如何利用这些知识成功地利用 ILC 的活性进行抗癌治疗。